期刊文献+

乳腺黏液癌淋巴结转移的高危因素及其对预后的影响 被引量:1

Risk factors of lymph node metastasis in patients with mucinous breast cancer and its influence on prognosis
原文传递
导出
摘要 目的探讨乳腺黏液癌淋巴结转移的高危因素及其对预后的影响。方法收集183例乳腺黏液癌患者的临床病理资料及生存情况,采用Logistic回归模型分析与黏液癌淋巴结转移相关的,临床病理因素,并分析其预后。结果183例乳腺黏液癌患者中共35例(19.1%)出现淋巴结转移。单因素分析显示,肿瘤大小、组织学亚型、雌激素受体(ER)、人表皮生长因子受体2(HER-2)、分子分型与乳腺黏液癌淋巴结转移相关(P均〈0.05)。多因素分析显示,肿瘤大小他~4(P=0.044)、混合型(P=0.031)、非LuminalA型(P=0.000)是乳腺黏液癌淋巴结转移的独立高危因素。淋巴结转移与无转移患者的5年无病生存率分别是83.0%、97.4%(P〈0.05),5年总体生存率分别是88.5%、99.1%(P〈0.05)。结论乳腺黏液癌的淋巴结转移少,肿瘤大小〉2cm、混合型、非LuminalA型是其淋巴结转移的高危因素。淋巴结转移的乳腺黏液癌预后较差。 Objective To investigate the risk factors of lymph node metastasis and prognostic role in patients with mueinous breast cancer(MBC). Methods The clinicopathological data and survival status of 183 patients with MBC were collected. Logistic regression analysis were performed to identify the relevance of clinicopathological features with lymph node metastasis in MBC, and the prognosis were analyzed. Results Lymph node metastases were found in 35 patients ( 19. 1% ) of all the patients. Univari ate analysis showed that tumor size, histologic subtypes, ER, HER-2, molecular subtypes were significantly correlated with lymph node metastasis in MBC ( P 〈 0. 05 ). Tumor size T2 - 4 ( P = 0. 044), mixed type ( P = 0. 031 ), non-Luminal A type ( P = 0. 000) were the risk factors of lymph node metastasis in MBC via multivariate analysis. The 5-year disease-free survival (DFS) of patients with lymph node metastasis or not were 83.0% and 97.4% (P 〈0. 05) respectively, and the 5-year overall survival were 88.5% and 99. 1% (P 〈 0. 05 ) respectively. Conclusions The lymph node metastasis were rare in MBC. Tumor size T2 - 4, mixed type, non-Luminal A type were the risk factors of lymph node metastasis in MBC. The MBC with lymph node metastasis had poor prognosis.
出处 《中国实用医刊》 2016年第12期50-53,共4页 Chinese Journal of Practical Medicine
关键词 乳腺黏液癌 淋巴结转移 高危因素 预后 Mucinous breast cancer Axillary lymph node metastasis Risk factor Prognostic role
  • 相关文献

参考文献18

  • 1Bae SY, Choi MY, Cho DH, et al. Mucinous carcinoma of the breast in comparison with invasive ductal carcinoma: clinicopatho- logic characteristics and prognosis[ J]. Breast Cancer, 2011, 14 (4) : 308-313.
  • 2Reis-Filho JS, Ellis IO. WHO classification of tumours of the breast[ S]. IARC: Lyon, 2012.
  • 3Vo T, Xing Y, Meric-Bernstam F, et al. Long-term outcomes in pa- tients with mueinous, medullary, tubular, and invasive ductal carci- nomas after lumpectomy[J]. Am J Surg, 2007, 194(4) : 527-531.
  • 4Di Saverio S, Gutierrez J, Avisar E. A retre~pective review with long term follow up of 11 ,zl00 eases of pure mueinous breast carcinoma[ J ].Breast Cancer Res Treat, 2008, 111(3) : 541-547.
  • 5Diab SG, Clark GM, Osborne CK, et al. Tumor characteristics and clinical outcome of tubular and mucinous breast carcinomas [ J ]. J Clin Oncol, 1999, 17(5): 1442-1442.
  • 6Goldhirsch A, Winer EP, Coates AS, et al. Personalizing the treatment of women with early breast cancer: highlights of the St Gallen International'Expert Consensus on the Primary Therapy of Early Breast Cancer 2013 [ J]. Ann Oncol, 2013, 24 (9) : 2206 -2223.
  • 7Anderson WF, Chu KC, Chang S, et al. Comparison of age-specific incidence rate patterns for different histopathologie types of breast car- cinoma[ J]. Cancer Epidemiol Biomarkers Prey, 2004, 13 ( 7 ) : 1128-1135.
  • 8Park S, Koo J, Kim JH, et al. Clinicopathological characteristics of mueinous carcinoma of the breast in Korea: comparison with invasive duetal carcinoma-not otherwise specified [ J ]. J Korean Med Sei, 2010, 25(3) : 361-368.
  • 9Li CI. Risk of mortality by histologie type of breast cancer in the Unit- ed States [ J ]. Horm Cancer, 2010, 1 (3) : 156-165.
  • 10Memis A, Ozdemir N, Parildar M, et al. Mutinous(colloid) breast canc- er: mammographic and US features with histologic correlation[J]. Eur J Radiol, 2000, 35(1 ): 39-43.

同被引文献14

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部